Fundraising Fox

Donmienne Leung

InvestorFounder

Director II, Head of AbbVie Ventures Europe at AbbVie · CEO at ThirtyFiveBio Limited

Oxford, England, United Kingdom

FoundedThirtyFiveBio Limited

About

Donmienne Leung leads a dedicated European venture mandate and, after 20+ years as a drug hunter and PhD medicinal chemist with active publications, provides hands-on scientific guidance to biotech boards.

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtech

CEO at ThirtyFiveBio Limited

Intro paths

In turn, Donmienne can intro founders to ThirtyFiveBio Limited's investors below.

ThirtyFiveBio Limited's investors · 1

Experience

  1. AbbVieDirector II, Head of Ventures Europecurrent2025 — presentOxford
  2. AbbVieDirector, AbbVie Ventures UK/Europe2023 — 2025Oxford, England, United Kingdom
  3. ThirtyFiveBioBoard Membercurrent2025 — present
  4. CephagenixBoard Membercurrent2025 — presentParis and Copenhagen
  5. EvolveImmune TherapeuticsBoard Membercurrent2024 — presentBranford, Connecticut, United States
  6. Endlyz TherapeuticsBoard Membercurrent2023 — presentOxford, England, United Kingdom
  7. Enthera PharmaceuticalsBoard Observer2023 — 2025Milan, Lombardy, Italy
  8. DISCO Pharmaceuticals GmbHBoard Observer2023 — 2025Cologne, North Rhine-Westphalia, Germany
  9. Absolute BiotechHead of Protein Engineering2021 — 2023Redcar
  10. Eli Lilly and CompanySenior Research Advisor2020 — 2021
  11. Eli Lilly and CompanyResearch Advisor2017 — 2020Greater San Diego Area
  12. Eli Lilly and CompanyPrinicipal Research Scientist2012 — 2017
  13. Eli Lilly and CompanySenior Research Scientist2008 — 2012
  14. Eli Lilly and CompanyResearch Scientist2005 — 2008
  15. The Scripps Research InstitutePostdoctoral Scientist2001 — 2005San Diego, California, United States
  16. University of QueenslandPHD Student1997 — 2001Brisbane, Australia
  17. University of MelbourneHonors Student1996 — 1997Melbourne, Victoria, Australia
  18. Walter and Eliza Hall Institute of Medical ResearchResearch Assistant1994 — 1996Melbourne, Victoria, Australia

Education

  1. The University of QueenslandDoctor, Philosophy1997 — 2000
  2. University of MelbourneBachelor of Science (Honours), Chemistry / Biochemistry1996
  3. University of MelbourneBachelor of Science & Bachelor of Engineering, Biochemistry1992 — 1995

Skills & more

ResearchBiopharmaceuticalsDrug Discovery26Protein Engineering10Chemistry5Antibodies9Protein Chemistry14Chemical Biology2Biochemistry13Protein Purification3Assay Development2Molecular Biology6
+12 moreHPLCDrug DevelopmentMedicinal ChemistryCell BiologyCell CultureBiotechnologyImmunologyELISAChromatographyWestern BlottingVolunteeringDrug Design

Languages Chinese · English

  • VC UniversityVC University

From Donmienne's professional profile.

Colleagues at AbbVie

Frequently asked questions

Where does Donmienne Leung work?
Donmienne Leung is Director II, Head of AbbVie Ventures Europe at AbbVie and CEO at ThirtyFiveBio Limited.
What does Donmienne Leung invest in?
Donmienne Leung invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech.
What companies did Donmienne Leung found?
Donmienne Leung founded ThirtyFiveBio Limited.

Founder mafias

Same school

Shared employers